A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer
Clinical trial NCT02146313 · COMPLETED
Trial details
- NCT number
- NCT02146313
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-22
- Primary completion
- 2018-06-18
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.